The largest database of trusted experimental protocols

M3262

Manufactured by Merck Group
Sourced in United States

The M3262 is a laboratory instrument designed for conducting various scientific experiments and analysis. It is a versatile piece of equipment that can be used in a wide range of research and testing applications. The core function of the M3262 is to provide precise and reliable measurements, data processing, and sample preparation capabilities to support the needs of scientific and research-oriented environments.

Automatically generated - may contain errors

11 protocols using m3262

1

Intravitreal Injection of AAV2-shMlkl, TNF, and NMDA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animals were anaesthetized by intraperitoneal injection of ketamine (80 mg/kg)/xylazine (10 mg/kg). Intravitreal injections were performed under a microsurgical microscope using glass pipettes with a diameter of approximately 150 µm at the tip. Each eye was punctured at the upper nasal limbus and a volume of 2 μl of the viral particles (AAV2-shMlkl or scrambled viral particles), TNF (0.5 ng/µl in PBS, RMTNFAI, ThermoFisher Scientific, US), NMDA (10 mM in PBS, M3262, MilliporeSigma, US), or TNF/NMDA was injected. To allow diffusion of the solution, the pipette was kept in place for about 15 s.
+ Open protocol
+ Expand
2

Intravitreal NMDA Injection in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were anesthetized with an intraperitoneal injection of Avertin, 125 mg per kg of body weight of 2,2,2-tribromoethanol diluted in 2-methyl-2-butanol (#T48402; and #240486; respectively, MilliporeSigma, Burlington, MA, USA), followed by proparacaine eye drops (0.5% Proparacaine Hydrochloride Ophthalmic Solution; Sandoz Inc., Princeton, NY, USA) for topical anesthesia. Pupils were dilated by instillation of 5% phenylephrine and 0.5% tropicamide eye drops (Massachusetts Eye and Ear Infirmary Pharmacy, Boston, MA, USA). Consequently, a conjunctival incision was made temporally and a sclerotomy was created approximately 3–4 mm from the limbus. A 33- gauge needle (Hamilton Custom Needles: Length: 10.00mm/Point Style: 4/Angle: 20, #7803–05; Hamilton Company, Reno, NV, USA) connected to a 10-µl syringe (Hamilton, 701RN SYR, #7635–01; Hamilton Company, Reno, NV, USA) was then inserted into the intravitreal cavity and 2 µl of NMDA (100 nmoles, #M3262; MilliporeSigma, Burlington, MA, USA) or vehicle (phosphate buffer saline-PBS) were injected slowly into the intravitreal space. Special care was given to avoid hitting the lens. At the end of the procedure antibiotic ophthalmic ointment (Bacitracin Zinc Ointment; Fougera Pharmaceuticals Inc., Melville, NY, USA) was applied to prevent potential infection. Any eyes with cataract and/or hemorrhage were excluded from the analysis.
+ Open protocol
+ Expand
3

Intrathecal Activation of Spinal Nociception

Check if the same lab product or an alternative is used in the 5 most similar protocols
To permit direct activation of spinal nociceptive circuitry, animals received intrathecal delivery of the glutamate receptor agonist N-methyl-D-aspartate (NMDA) (M3262, Sigma Aldrich, St. Louis, MO) or the NK1 receptor agonist substance P (sP) (S6883, Sigma Aldrich, St. Louis, MO). Two days after BoNT-B or vehicle pre-treatment, anesthesia was induced and maintained with 2.5% isoflurane. Maintenance anesthesia was administered via a nosecone. Mice were then intrathecally (i.t.) injected between the L5 and L6 vertebrae with 5 μL of NMDA (0.25nM), sP (3.71 pM) or saline. A flick of the tail upon insertion of the needle was taken to indicate appropriate needle placement. Mice remained anesthetized and the spinal cords were harvested 5 min post-injection for western blot analysis of pAkt and pGluA1.
+ Open protocol
+ Expand
4

NMDAR-dependent Long-term Depression Induction

Check if the same lab product or an alternative is used in the 5 most similar protocols
NMDAR-dependent LTD was induced with 30 µM NMDA (Sigma, M3262)4 (link),16 (link). On the 14th day in vitro (14DIV) the slices were placed in 1 ml of culture medium supplemented with 30 µM NMDA for 4 min. Then the inserts were moved back to the old CM for additional 26 minutes. In the control group, inserts were moved to fresh CM for 4 min and back to the old CM for additional 26 minutes.
+ Open protocol
+ Expand
5

Pharmacological Interventions for Animal Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
NMDA (M3262, Sigma, United States) was dissolved in phosphate buffered saline (PBS) to prepare solutions for different modeling methods (immersion: 300 and 500 μmol/L; intraperitoneal injection: 8 and 16 mg/kg; intravitreal injection: 0.1 and 0.5 mol/L). MK-801 (M107, Sigma, United States) was soluble in 500 mL/L ethanol (intraperitoneal injection: 3 mg/kg, intravitreal injection: 0.05 mol/L). Resveratrol (R5010, Sigma, United States) was dissolved in 1000 mL/L ethanol and kept in the dark during storage and during the whole experiment (40 mg/L). Distilled water was used to dissolve MS-222 (A5040, Sigma, United States) (0.2 g/L). The timeline of drug delivery is shown in Figure 1.
+ Open protocol
+ Expand
6

Glucose-Stimulated Insulin Secretion Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
As previously described [1 (link),26 (link)], pancreatic islets were isolated via ductal inflation with 0.75 mg/mL collagenase P (Roche 11213865001) and handpicked clean into RPMI media for an overnight rest in a humidified incubator at 37 °C, 5% CO2 before use. For in vitro GSIS, islets were pre-incubated for 2 h in 2 mM (low) glucose in a Krebs buffer, then 10 islet aliquots were picked into cell culture inserts in a 24-well plate (2–3 wells per condition per N). Islets were incubated sequentially in low glucose (LG) and then high glucose (22 mM, HG) for 30 min each. For some experiments, a combination of NMDA (Sigma Aldrich, M3262) and/or D-serine (Sigma Aldrich, S4250), dissolved in sterile water to 10, 100, or 1000 mM stocks, was diluted into LG/HG solutions 1000-fold to their final concentrations. GSIS insulin secretion is presented normalized to the total insulin content of the islets collected at the end of the experiment. Islet insulin content was calculated as the sum of the total insulin released and the final islet insulin, normalized to the DNA of the collected islets in each well (Quant-iT Pico-Green dsDNA Assay Kit, Molecular Probes, Eugene, OR, USA). With the exception of the high fat diet (HFD) experiment, all GSIS data was derived from at least 2 independent experiments.
+ Open protocol
+ Expand
7

NMDA Intravitreal Injection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
NMDA intravitreal injections were performed as previously described [28 (link)], Briefly, animals were anesthetized with 100 mg/kg ketamine and 10 mg/kg xylazine. The sclera was cleared with the bevel of a 33 G needle, which was then used to poke a small hole just behind the limbus. A Hamilton needle was used to deliver 2 μL of 100 mM NMDA (Sigma-Aldrich, M3262) or PBS (vehicle control). Injections were performed over the course of approximately 2 minutes to avoid sudden increases in intraocular pressure.
+ Open protocol
+ Expand
8

NMDA-Mediated Calcium Signaling in Motor Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
On day 28 in vitro (MNs-DIV 0), MNPs were seeded in Matrigel (Corning #354230)-coated glass Petri dishes and cultured with HopCell® Human MN differentiation culture medium. The culture medium was subsequently replaced with the neurobasal medium. By DIV 30, we performed calcium signal recording and N-methyl-D-aspartate (NMDA) stimulation experiments. We removed the existing medium from the Petri dish and carefully added 300–500 μL of preheated (at 37°C) magnesium-free extracellular solution. Baseline recordings were made via video microscopy for a duration of 50–200 s. Without pausing the video, 300–500 μL of a mixture containing NMDA (200 μM; Sigma #M3262) and Glycine (20 μM) (Sigma#G7126) was added. An increase in neuronal discharge was observed and recorded for 150–200 s. After introducing 100 μL of MK801 (5 μM) (MCE#HY-15084-10) near the neuron, a gradual decrease in the intensity of neuronal discharge was noted and recorded for 150–200 s.
+ Open protocol
+ Expand
9

Intraocular Injection Protocol for Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were anesthetized via inhalation of 2.5% isoflurane in oxygen and intraocular injections performed as described previously (Todd and Fischer, 2015 (link)). For all experiments, the vitreous chamber of right eyes of mice were injected with the experimental compound and the contralateral left eyes were injected with a control vehicle. Compounds used in these studies are as follows: N-methyl-D-aspartate (NMDA; 1.5ul of 100mM in PBS; Sigma; M3262), recombinant mouse IL1β (200 ng/dose; R&D systems; 401-ML) recombinant mouse TNF (250 ng/dose; BioLegend; 575204), recombinant mouse Osteopontin (OPN; 200ng/dose; BioLegend; 763604), CNTF (300ng/dose; R&D systems; 557-NT), FGF2 (250 ng/dose; R&D systems; 233-FB), Dexamethasone (Dex; 250ng/dose; MP Biomedicals; 194561), WNT4 (1ug/dose; Abcam; ab236179); CU-T12–9 (TLR1/2 agonist; 2.5ug/dose; Tocris; 5414), CU-CPT22 (TLR antagonist; 2.5ug/dose; Tocris; 4884), and a cocktail of three different GSK3β inhibitors (referred to as ABC) which included 1-Azakenpaullone (1-AP; 500 ng/dose; Selleck Chemicals; S7193), BIO (500 ng/dose; R&D Systems; 3194), CHIR 99021 (500 ng/dose; R&D Systems; 4423).
+ Open protocol
+ Expand
10

NMDA-Induced Cell Stimulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two experimental groups were established. In the first group, the cells were kept under control conditions (no stimulation), whereas in the second group, the cells were stimulated with NMDA 100 µM (Sigma-Aldrich #M3262).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!